Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib.
Kaklamani VG, Siziopikou K, Scholtens D, Lacouture M, Gordon J, Uthe R, Meservey C, Hansen N, Khan SA, Jeruss JS, Bethke K, Cianfrocca M, Rosen S, Von Roenn J, Wayne J, Parimi V, Jovanovic B, Gradishar W. Kaklamani VG, et al. Breast Cancer Res Treat. 2012 Apr;132(3):833-42. doi: 10.1007/s10549-011-1411-8. Epub 2011 Feb 27. Breast Cancer Res Treat. 2012. PMID: 21359953 Clinical Trial.
Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, Blau S, Bodin BE, Borno HT, Castellano C, Choi H, Deeken J, Desai A, Edwin N, Feldman LE, Flora DB, Friese CR, Galsky MD, Gonzalez CJ, Grivas P, Gupta S, Haynam M, Heilman H, Hershman DL, Hwang C, Jani C, Jhawar SR, Joshi M, Kaklamani V, Klein EJ, Knox N, Koshkin VS, Kulkarni AA, Kwon DH, Labaki C, Lammers PE, Lathrop KI, Lewis MA, Li X, de Lima Lopes G, Lyman GH, Makower DF, Mansoor AH, Markham MJ, Mashru SH, McKay RR, Messing I, Mico V, Nadkarni R, Namburi S, Nguyen RH, Nonato TK, O'Connor TL, Panagiotou OA, Park K, Patel JM, Patel KG, Peppercorn J, Polimera H, Puc M, Rao YJ, Razavi P, Reid SA, Riess JW, Rivera DR, Robson M, Rose SJ, Russ AD, Schapira L, Shah PK, Shanahan MK, Shapiro LC, Smits M, Stover DG, Streckfuss M, Tachiki L, Thompson MA, Tolaney SM, Weissmann LB, Wilson G, Wotman MT, Wulff-Burchfield EM, Mishra S, French B, Warner JL, Lustberg MB, Accordino MK, Shah DP. Nagaraj G, et al. medRxiv [Preprint]. 2023 Mar 10:2023.03.09.23287038. doi: 10.1101/2023.03.09.23287038. medRxiv. 2023. Update in: Elife. 2023 Oct 17;12:e82618. doi: 10.7554/eLife.82618. PMID: 37205429 Free PMC article. Updated. Preprint.
TGF-beta signaling alterations in cancer.
Bian Y, Kaklamani V, Reich J, Pasche B. Bian Y, et al. Cancer Treat Res. 2003;115:73-94. doi: 10.1007/0-306-48158-8_3. Cancer Treat Res. 2003. PMID: 12613193 Review. No abstract available.
Role of capecitabine (Xeloda) in breast cancer.
Kaklamani VG, Gradishar WJ. Kaklamani VG, et al. Expert Rev Anticancer Ther. 2003 Apr;3(2):137-44. doi: 10.1586/14737140.3.2.137. Expert Rev Anticancer Ther. 2003. PMID: 12722873 Review.
Adjuvant therapy of breast cancer.
Kaklamani VG, Gradishar WJ. Kaklamani VG, et al. Cancer Invest. 2005;23(6):548-60. doi: 10.1080/07357900500202937. Cancer Invest. 2005. PMID: 16203663 Review.
Adjuvant therapy of breast cancer.
Kaklamani VG, Gradishar WJ. Kaklamani VG, et al. Minerva Ginecol. 2005 Oct;57(5):521-36. Minerva Ginecol. 2005. PMID: 16205597 Review.
Transforming Growth Factor Beta and breast cancer.
Kaklamani V, Pasche B. Kaklamani V, et al. Cancer Treat Res. 2005;126:129-56. doi: 10.1007/0-387-24361-5_6. Cancer Treat Res. 2005. PMID: 16209065 Review. No abstract available.
Gene expression in breast cancer.
Kaklamani VG, Gradishar WJ. Kaklamani VG, et al. Curr Treat Options Oncol. 2006 Mar;7(2):123-8. doi: 10.1007/s11864-006-0047-0. Curr Treat Options Oncol. 2006. PMID: 16455023 Review.
147 results